{"id":48637,"date":"2022-09-21T12:02:06","date_gmt":"2022-09-21T10:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/"},"modified":"2022-09-21T12:02:06","modified_gmt":"2022-09-21T10:02:06","slug":"s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/","title":{"rendered":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France"},"content":{"rendered":"
\n

LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2\u2019s Singulator\u2122 100 System and associated products for single-cell genomics and cell biology applications in France.\n<\/p>\n

<\/a><\/p>\n

\nThis partnership focuses on expanding S2 Genomics\u2019 Singulator\u2122 100 System product line to France, through Proteigene\u2019s strong customer-centric sales force, as well as its customer base. This agreement further iterates both companies\u2019 willingness to drive growth and build relationships with customers in France.\n<\/p>\n

\n\u201cWe are very excited about the partnership between S2 Genomics and Proteigene as this aligns with our global growth initiatives to create a value-added supply chain for our customers, specifically for all areas of single cell genomics and cell biology spurring demand for improved, fully automated single-cell preparation solutions,\u201d said Dr. Stevan Jovanovich, S2 Genomics\u2019 Chief Executive Officer. \u201cWith Proteigene\u2019s in-depth understanding of the single cell genomics field and strong local presence, it creates an opportune moment for us to deliver the best solution to customers.\u201d said, Dr. Ravi Vinayak, VP of Global Channel Sales for S2 Genomics.\n<\/p>\n

\n\u201cAt Proteigene, we are continuously evolving and developing innovative solutions to transform customers processes. Therefore, enhancing our single cell genomics portfolio has been a strategic initiative,\u201d stated Antoine Dutriat, CFO, of Proteigene. \u201cWe are delighted to be partnering with S2 Genomics. With Singulator\u2122 100 system we found an innovative, robust, and unique technology that perfectly complements our growing portfolio. Adding S2\u2019s fully automated tissue dissociation system is a natural fit for our ever-expanding customer base. As a leading solution provider in the genomics field, this strategic partnership is perfect for our two companies.\u201d\n<\/p>\n

\nAbout S2 Genomics, Inc<\/b>.\n<\/p>\n

\nS2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for single-cell applications. S2 Genomics\u2019 technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for single-cell sequencing and cell biology applications, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit https:\/\/S2Genomics.com<\/a>.\n<\/p>\n

\nAbout Proteigene<\/b>\n<\/p>\n

\nProteigene is a full service distributor with a team of sales representatives, product specialists and systems engineers, ready to support researchers in the fields of genomics, cell biology, biobanking and liquid handling. Proteigene offers cutting-edge and innovative technologies and has 20 years of experience selling and supporting life science instrumentation and associated consumables. For more information, visit www. Proteigene.com.<\/a>\n<\/p>\n

\nFor Research Use Only. Not for use in diagnostic procedures.\n<\/p>\n

\nS2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDr. Ravi Vinayak, VP Global Channel Sales, S2 Genomics, Inquiries@s2genomics.com<\/a>.
\n
Dr Olivier Leroy, Genomics & Single Cell Product Manager, Proteigene, info@proteigene.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2\u2019s Singulator\u2122 100 System and associated products for single-cell genomics and cell biology applications in France. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48637","6":"format-standard","7":"category-industry"},"yoast_head":"\nS2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2\u2019s Singulator\u2122 100 System and associated products for single-cell genomics and cell biology applications in France. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-21T10:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France\",\"datePublished\":\"2022-09-21T10:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/\"},\"wordCount\":489,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005030\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/\",\"name\":\"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005030\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"datePublished\":\"2022-09-21T10:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005030\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005030\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/","og_locale":"en_US","og_type":"article","og_title":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend","og_description":"LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2\u2019s Singulator\u2122 100 System and associated products for single-cell genomics and cell biology applications in France. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-21T10:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France","datePublished":"2022-09-21T10:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/"},"wordCount":489,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/","url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/","name":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg","datePublished":"2022-09-21T10:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220921005030\/en\/834457\/21\/S2G-Primary-Gradient.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-new-distribution-partnership-to-advance-single-cell-research-for-the-singulator-100-system-with-proteigene-in-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator\u2122 100 System with Proteigene in France"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48637"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48637\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}